Brain Death clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Intravenous Thyroxine for Heart-Eligible Organ Donors
open to eligible people ages 14-55
This randomized controlled trial will evaluate whether intravenous thyroxine infusion given to brain-dead organ donors who are eligible to donate hearts for 12 hours will result in more hearts transplanted than saline placebo
at UCSD
Last updated: